Creeping Over the Chasm: Biotech's Perilous Managerial Transitions
Executive Summary
Clinical challenges are tough enough; a new study shows that biotechs struggle with the basics of managerial transitions. With over 80% of companies reporting a significant organizational transformation-many because they've changed business models from discovery to development-the problem has major implications for strategies and for investors.